Author： Norman Peter
Publisher： Informa Healthcare
ISSN： 1354-3776
Source： Expert Opinion on Therapeutic Patents, Vol.12, Iss.9, 2002-09, pp. : 1407-1415
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
SmithKline Beecham: analysis of patenting 1995 - 1998
By Adams S.
Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 9, 1999-09 ,pp. :
Access to resources
Recommend
GlaxoSmithKline extends preferential pricing
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 319, 2001-01 ,pp. :
GlaxoSmithKline stops salmeterol study
Inpharma, Vol. 1, Iss. 1373, 2003-01 ,pp. :
GlaxoSmithKline Medal of Merit 2008
JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 38, Iss. 4, 2008-12 ,pp. :
GlaxoSmithKline Medal of Merit 2010
JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 40, Iss. 4, 2010-12 ,pp. :